Literature DB >> 27464552

Nephroprotection of punicalagin in rat model of endotoxemic acute kidney injury.

Amr A Fouad1, Hatem O Qutub2, Walid N Al-Melhim3.   

Abstract

The potential nephroprotection of punicalagin (PNG) against lipopolysaccharide (LPS)-induced acute kidney injury in rats was investigated. Rats received a single i.v. dose of LPS (5 mg/kg), and treated with PNG (50 mg/kg, i.p.), 1 h before, and 1 h following LPS administration. LPS caused significant increases of serum creatinine and neutrophil gelatinase-associated lipocalin. LPS also resulted in significant increases in interleukin-18, tumor necrosis factor-α, interleukin-6, malondialdehyde, nitric oxide, Bax/Bcl-2 ratio and myeloperoxidase, inducible nitric oxide synthase, caspases 3, 8 and 9 activities, and a significant decrease in total antioxidant capacity in kidney tissues. PNG significantly ameliorated the alterations in the measured parameters. Additionally, PNG attenuated the histopathological injury and reduced kidney injury molecule-1 expression in kidneys of rats that received LPS. It was concluded that PNG ameliorated endotoxemic acute kidney injury in rats by counteracting inflammation, oxidative/nitrative stress and apoptosis.

Entities:  

Keywords:  Endotoxemia; kidney; punicalagin; rats

Mesh:

Substances:

Year:  2016        PMID: 27464552     DOI: 10.1080/15376516.2016.1211207

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  3 in total

Review 1.  Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia.

Authors:  Zixuan Liu; Wenxiang Wang; Jie Luo; Yingrui Zhang; Yunsen Zhang; Zhiqiang Gan; Xiaofei Shen; Yi Zhang; Xianli Meng
Journal:  Front Pharmacol       Date:  2021-04-21       Impact factor: 5.810

2.  Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation.

Authors:  Jung Lo; Ching-Chih Liu; Yueh-Shan Li; Po-Yen Lee; Po-Len Liu; Pei-Chang Wu; Tzu-Chieh Lin; Chi-Shuo Chen; Chien-Chih Chiu; Yu-Hung Lai; Yo-Chen Chang; Hsin-En Wu; Yuan-Ru Chen; Yu-Kai Huang; Shu-Pin Huang; Shu-Chi Wang; Chia-Yang Li
Journal:  J Inflamm Res       Date:  2022-09-15

Review 3.  Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases.

Authors:  Jie Xu; Ke Cao; Xuyun Liu; Lin Zhao; Zhihui Feng; Jiankang Liu
Journal:  Antioxidants (Basel)       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.